Sotac Pharmaceuticals Ltd (SOTAC) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: SOTAC | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

Sotac Pharmaceuticals Ltd (SOTAC) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: SOTAC | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Sotac Pharmaceutical

Based on:

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Somewhat overvalued

3. Price Trend

Sotac Pharmaceuticals stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
31.58
Market Cap:
150.7 Cr.
52-wk low:
0
52-wk high:
0

Is Sotac Pharmaceuticals Ltd an attractive stock to invest in?

1. Is Sotac Pharmaceuticals Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Sotac Pharmaceuticals Ltd is a average quality company.

2. Is Sotac Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of Sotac Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Sotac Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Sotac Pharmaceuticals Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

10 Year X-Ray of Sotac Pharmaceutical:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Sotac Pharmaceuticals Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 11%16.4%41.6%29.8%19.3%11.4%-
Value Creation
Index
-0.20.22.01.10.4-0.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 28.643.473.25867.162.462
Sales YoY Gr.-51.9%68.4%-20.7%15.8%-7.1%-
Adj EPS 0.91.15.75.65.14.14.3
YoY Gr.-21.6%431.8%-1.8%-8.9%-20.2%-
BVPS (₹) 4.25.28.814.343.74848
Adj Net
Profit
0.70.94.64.55.64.55
Cash Flow from Ops. -0.32.43.68.5-19.8-6.1-
Debt/CF from Ops. -28.62.82.11.3-0.6-3.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA16.9%-5.2%-7.1%
Adj EPS NA35.8%-10.6%-20.2%
BVPSNA62.9%75.9%9.8%
Share Price - - - 23.2%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
20.922.780.932.116.38.99
Op. Profit
Mgn %
7.26.51114.214.912.313.2
Net Profit
Mgn %
2.526.37.88.47.27.7
Debt to
Equity
2.11.610.90.20.4-
Working Cap
Days
01081011711992940
Cash Conv.
Cycle
0-5-15-8441150

Recent Performance Summary

Debt to equity has declined versus last 3 years average to 0.38

Return on Equity has declined versus last 3 years average to 9.00%

Sales growth has been subdued in last 3 years -5.17%

Net Profit has been subdued in last 3 years -10.64%

Sales growth is not so good in last 4 quarters at 5.05%

Latest Financials - Sotac Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 4.3 7.3
TTM Sales (₹ Cr.) 62.4 97
BVPS (₹.) 48 48.2
Reserves (₹ Cr.) 42 42
P/BV 2.84 2.83
PE 31.58 18.77
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 151
Equity (₹ Cr.) 11.1
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Sotac Pharmaceutical:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Sotac Pharmaceutical - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Sotac Pharmaceutical

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales294373586762
Operating Expenses 274167505755
Manufacturing Costs225576
Material Costs213456404544
Employee Cost 122211
Other Costs 224334
Operating Profit 2368108
Operating Profit Margin (%) 7.2%6.5%8.5%14.2%14.9%12.3%
Other Income 000012
Interest 011111
Depreciation 111232
Exceptional Items 000000
Profit Before Tax 115686
Tax 001122
Profit After Tax 113465
PAT Margin (%) 2.5%2.0%4.5%7.8%8.6%7.6%
Adjusted EPS (₹)0.91.14.15.65.24.3
Dividend Payout Ratio (%)0%0%14%0%0%2%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 347124853
Share Capital 22281111
Reserves 12533742
Minority Interest000000
Debt7669912
Long Term Debt331746
Short Term Debt445256
Trade Payables10102018159
Others Liabilities 11316411
Total Liabilities 212236557685

Fixed Assets

Gross Block91011182425
Accumulated Depreciation342469
Net Fixed Assets 669141817
CWIP 000000
Investments 22041113
Inventories245101110
Trade Receivables8613112225
Cash Equivalents 0001010
Others Assets 231061320
Total Assets 212236557685

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -0249-20-6
PBT 115686
Adjustment 223202
Changes in Working Capital -2-0-32-26-14
Tax Paid -0-0-1-2-2-1
Cash Flow From Investing Activity -2-1-3-11-13-2
Capex 0-1-4-7-6-1
Net Investments -2-00-4-7-2
Others 000011
Cash Flow From Financing Activity 2-1-012238
Net Proceeds from Shares 1009330
Net Proceeds from Borrowing -4-0-66-21
Interest Paid -0-1-1-1-1-1
Dividend Paid 00-0000
Others 5-06-2-78
Net Cash Flow -0-0010-9-0

Finance Ratio

PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)20.9322.7158.2348.2919.239.42
ROCE (%)10.9816.4341.5629.7619.2811.44
Asset Turnover Ratio1.352.022.511.271.030.77
PAT to CFO Conversion(x)-021.332.25-3.33-1.2
Working Capital Days
Receivable Days10459467691137
Inventory Days302623475662
Payable Days17010898173133100

Sotac Pharmaceuticals Ltd Stock News

Sotac Pharmaceuticals Ltd FAQs

The current trading price of Sotac Pharmaceutical on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Sotac Pharmaceutical stood at ₹150.7.
The latest P/E ratio of Sotac Pharmaceutical as of 31-Dec-1969 is 31.58.
The latest P/B ratio of Sotac Pharmaceutical as of 31-Dec-1969 is 2.84.
The 52-week high of Sotac Pharmaceutical is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sotac Pharmaceutical is ₹62.38 ( Cr.) .

About Sotac Pharmaceuticals Ltd

The company was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 (Partnership Act) in the name and style of Sotac Pharmaceuticals, pursuant to a deed of partnership dated December 10, 2014. Thereafter Sotac Pharmaceuticals was converted from Partnership Firm to a Private Limited Company under Part I (Chapter XXI) of the Companies Act, 2013 in the name of Sotac Pharmaceuticals Private Limited and received a certificate of incorporation dated December 18, 2015 from the Assistant Registrar of Companies, Gujarat. Later on the company was converted into a Public Limited Company pursuant to shareholders resolution passed at Extra-ordinary General Meeting of the Company held on November 12, 2022 and the name of the Company was changed to Sotac Pharmaceuticals Limited. A fresh Certificate of Incorporation consequent upon Conversion from Private Limited Company to Public Limited Company dated November 22, 2022 was issued by the Registrar of Companies, Ahmedabad.

Sotac Pharmaceuticals is in business of manufacturing of pharmaceutical products for different marketers on loan license or contract manufacturing basis. Its business is majorly on principle to principle basis with different marketers. The company caters to corporate clients on loan licence and/or contract manufacturing basis. The company has commenced manufacturing facility in year 2017, hence, the company has experience of more than 5 years in the current line of business of the company. In year 2017, the company’s manufacturing facility was installed with capacity to manufacture 90 crore tables / year, 14 crore Capsules / year.

Business area of the company

The company specializes in the production of high-quality pharmaceutical products on a loan license or contract manufacturing basis. It has a diverse product portfolio that includes a wide range of pharmaceuticals, nutraceuticals, and food products.

Key Events/Milestone/ Achievement

  • 2015: The company was incorporated as a private limited company under the name Sotac Pharmaceuticals Private Limited.
  • 2019: Recognised as ‘Fastest Growing Indian Company’ with and Excellence Award by International Achievers Conference.
  • 2021: Received ‘Indo Global award for Business Excellence’ 2022.
  • 2022: The Company has acquired 53,25,000 Equity Shares in SOTAC Healthcare Private Limited making it subsidiary of the Company.
  • 2022: The Company has acquired 99,995 Equity Shares in SOTAC Research Private Limited making it wholly owned subsidiary of the Company.
  • 2022: The Company was converted into Public Limited Company under the name of ‘Sotac Pharmaceuticals Limited’.
  • 2022: Received recognition as for ‘Fastest Expansion of Project’ by Sanand Industries Association (SIA).
  • 2022: Recognized as one of the ‘Top 10 Pharma Contract Manufacturers in India’ by India Pharma Outlook.
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×